Two highly fluorinated bipyridine derivatives, (4,4′‐bis(R f CH 2 OCH 2 )‐2,2′‐bpy) {R f = n ‐C 10 F 21 ( 1a ), n ‐C 10 F 23 ( 1b )}, have been synthesized starting from 4,4′‐bis(BrCH 2 )‐2,2′‐bpy and the corresponding fluorinated alkoxides. The fluorine contents of ligands 1a‐b are 62.3% and 63.3%, respectively, both being white solids, virtually insoluble in CH 2 Cl 2 or DMF and highly fluorophilic with a partition ratio between DMF and n ‐C 8 F 18 less than 1:1000. The reaction of ligands 1a‐b with [Pd(CH 3 CN) 2 Cl 2 ] results in novel Pd complexes [PdCl 2 (4,4′‐bis‐(R f CH 2 OCH 2 )‐2,2′‐bpy)] where R f = n ‐C 10 F 21 ( 2a ), n ‐C 10 F 23 ( 2b ), respectively. The Pd complexes 2a‐b are pale yellow solids, soluble only in fluorinated solvents. The Pd complexes 2a‐b have been satisfactorily tested for Mizoroki‐Heck arylation under fluorous biphasic catalysis conditions in that the Pd complexes 2a‐b are easily recovered and maintain good catalytic activity after 8 consecutive cycles (> 90% yield). The TGA studies indicate that the Pd complexes 2a‐b are thermally stable up to 300 °C.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: